{"id":"W4416507992","doi":"10.1159/000549663","title":"Aflibercept 2 mg for Neovascular Age-Related Macular Degeneration: XTEND at 3 Years","year":2025,"lang":"en","type":"article","venue":"Ophthalmologica","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"Bayer","keywords":"Aflibercept; Ranibizumab; Macular degeneration; Eye disease; Neovascular glaucoma; Retinopathy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002968177,0.0003252315,0.0006970027,0.0003449887,0.0004184166,0.0008355738,0.0002917756,0.0004364471,0.001488453],"category_scores_gemma":[0.002004768,0.0001616731,0.0009071248,0.0006030352,0.0003239991,0.0008539716,0.0004086667,0.0007854732,0.0002817957],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006234748,"about_ca_system_score_gemma":0.0006275343,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008781542,"about_ca_topic_score_gemma":0.001106219,"domain_scores_codex":[0.9990153,0.0003467463,0.0001129965,0.0001852717,0.0002226853,0.0001169534],"domain_scores_gemma":[0.9979118,0.0002879331,0.001300694,0.00007591363,0.0001365399,0.0002871099],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08274589,0.003994748,0.7942495,0.0005384536,0.001126823,0.0003715005,0.0002797075,0.0006964476,0.003100388,0.0001419805,0.00177062,0.1109839],"study_design_scores_gemma":[0.008601547,0.04963073,0.9334297,0.0001597063,0.001100027,0.0008378839,0.00012073,0.0008821799,0.001256943,0.0001878662,0.003753112,0.00003947123],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991076,0.006003596,0.0001668705,0.0002292812,0.00002951496,0.0001829122,0.0008259603,0.00001907417,0.001466829],"genre_scores_gemma":[0.9970005,0.001014257,0.0002468757,0.0002336192,0.00007599607,0.0001190085,0.0008376171,0.000002858703,0.0004692847],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002968177,"threshold_uncertainty_score":0.01569742,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02172609614950701,"score_gpt":0.3166093684860293,"score_spread":0.2948832723365223,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}